Patient Pathfinder: Clinical Trials
Clinical Trials for Hypertrophic Cardiomyopathy
Every life-saving or life-extending treatment that’s available today for cancer started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand cancer, and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 28 active Hypertrophic Cardiomyopathy trials
A Multi-Center, Open Label Gene Therapy Study of RP-A501 in Male Patients With Danon Disease
Study Type: Interventional Phase 2
The Purpose of This Study is to Evaluate the Efficacy and Safety of Aficamten (CK-3773274) Compared to Placebo in Adults With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy
Study Type: Interventional Phase 3
Molecular Imaging of Myocardial Fibrosis in Cardiac Amyloidosis
Study Type: Interventional Phase 3
Mavacamten Pregnancy Surveillance Program
Study Type: Observational
The Purpose of This Study is to Compare the Efficacy and Safety of Aficamten (CK-3773274) Compared With Metoprolol Succinate in Adults With Symptomatic Hypertrophic Cardiomyopathy and Left Ventricular Outflow Tract Obstruction
Study Type: Interventional Phase 3
Study of Safety and Tolerability of TN-201 in Adults With Symptomatic MYBPC3 Mutation-associated HCM
Study Type: Interventional Phase 1
Exercise Intolerance in Non-obstructive Hypertrophic Cardiomyopathy
Study Type: Interventional
A Study of Mavacamten in Non-Obstructive Hypertrophic Cardiomyopathy
Study Type: Interventional Phase 3
There are 28 active Hypertrophic Cardiomyopathy trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now